SENIOR LEADERSHIP

Our deeply rooted compassion drives us to go beyond delivering life-changing therapies. We strive to positively impact the many aspects of rare patients’ lives.

Chris Cline, CFA, serves as the chief financial officer and member of the executive team at Travere Therapeutics. He is responsible for overseeing the company’s corporate and strategic finance, and investor relations activities. Mr. Cline brings more than 15 years of industry experience in investor relations, corporate communications, and financial strategy, planning and analysis to the chief financial officer position. Previously, Mr. Cline served as senior vice president, investor relations and corporate communications at Travere. Since joining Travere in 2014, Mr. Cline has been responsible for leading engagement with the investment community, as well as building a developed corporate communications infrastructure and strategy. Prior to Travere, Mr. Cline was a member of the global investor relations group at Elan Corporation, plc, and the financial planning and analysis group at Phase Forward. Mr. Cline is a CFA charter holder and holds a degree in finance from the Williams College of Business at Xavier University.